In 1961, Marshall W. Nirenberg and his postdoctoral fellow Johann H. Matthaei at the National Institutes of Health found that mixing polyuridylic acid (poly-U) with cell-free extracts from E. coli resulted in the production of proteins made entirely of phenylalanine (Nirenberg and Matthaei, 1961) . Using additional synthetic RNAs, including those with repeating triplets, Nirenberg and H. Gobind Khorana produced different monoand dipeptide proteins. Together, they deciphered the genetic code (Khorana, 1968) and, for this work, shared the 1968 Nobel Prize in Physiology or Medicine, along with Robert W. Holley, who first isolated tRNA.
Today, translation in eukaryote cells is recognized to be a highly regulated process. Initiation is the rate-limiting step and thus is the phase of protein synthesis most subject to regulation (Richter and Sonenberg, 2005) . Although initiation itself is a multi-step process, it culminates in 5 0 to 3 0 ''scanning'' of a complex containing the 40S ribosome subunit-often referred to as a 43S preinitiation complex that includes a ternary complex (TC) of eIF2, GTP, and initiator methionine tRNA. Usually upon encountering the first AUG codon, which more often than not resides in a favorable context (the 5 0 A/GCCAUGG 3 0 Kozak sequence that promotes initiation [Kozak, 1986; Hinnebusch et al., 2016] ), the preinitiation complex stops and recruits the 60S subunit, and polypeptide elongation begins ( Figure 1A) . 5 0 to the classic AUG initiation codon, however, it is now clear that many RNAs have upstream open reading frames (uORFs), which can serve several different roles in translation. Some uORFs lack a stop codon and begin with a canonical AUG initiator codon in-frame with the downstream AUG. In these cases, ''leaky'' scanning may occur where peptide synthesis occurs at both the uORF and downstream open reading frames (ORFs), resulting in two peptides distinct only at the amino terminus (Hinnebusch et al., 2016) . Other uORFs can suppress or prevent translation at the downstream ORF when a stop codon is present between them because ribosome re-initiation is not robust ( Figure 1B) . Moreover, scanning 40S ribosomal subunits can sometimes bypass the uORF altogether and initiate translation at the downstream AUG codon, which can be particularly robust when the uORF acts as an enhancer of downstream initiation (Ivanov et al., 2010) .
With the advent of next-generation sequencing and ribosome profiling, which together can map the positions and relative amounts of ribosomes on mRNA (Ingolia et al., 2009) , the following has become clear: (1) Most mRNAs have uORFs; and (2) These uORFs frequently use alternative (non-AUG) start codons. For example, Ingolia et al. (2011) and Lee et al. (2012) performed ribosome profiling in cultured cells in the presence of the translation inhibitor cycloheximide, which binds both initiating and elongating ribosomes, or of other drugs such as harringtonine and lactimidomycin, which bind initiating ribosomes with an exit (E) site that is devoid of tRNA. These drugs allow elongating ribosomes to run off the mRNA while maintaining the initiating ribosome in place, thereby enabling start codon identification on a global basis following sequencing of the RNAs protected by this initiating ribosome (an approach called global translation initiation sequencing, or GTI-seq). These and related analyses (e.g., Bazzini et al., 2014; Fields et al., 2015; Ji et al., 2015) have revealed that > 50% of mRNAs contain uORFs that are occupied by ribosomes, in close agreement with a similar proportion estimated by an earlier RNA-seq effort (Calvo et al., 2009 ). Use of GTI-seq has also demonstrated remarkable variation in translation initiation sites (uORF and ORF), with only 51% beginning with AUG, 16% with CUG, and 24% with other sequences (UUG, CUG, AGG, ACG, AAG, AUC, AUA, AUU). For uORFs in particular, 75% begin with non-AUG codons, with CUG (encoding leucine) being the most prevalent.
The preponderance of uORFs implies widespread regulation of downstream ORF translation (Morris and Geballe, 2000) , and it is the TC component eIF2a that is the key factor controlling uORF utilization. Phosphorylation of eIF2a serine 51 inhibits the activity of the guanine nucleotide exchange factor eIF2B, which in turn impedes formation of the 43S pre-initiation complex (PIC) and consequently reduces general translation. However, some mRNAs escape this inhibition and are translated even though they have uORFs. This is caused by stress-induced eIF2a phosphorylation and resulting TC limitation, which render uORF initiation unfavorable; it is thus bypassed, and initiation occurs at the downstream AUG. Examples of mRNAs under this type of regulation encode such proteins as the transcription factors CHOP (CCAAT-enhancer-binding protein homologous protein) and ATF4 and ATF5, the growth arrest and DNA damage-inducible protein GADD34, among many others (Baird et al., 2014; Young and Wek, 2016) . Added to this, a peptide encoded by the uORF in CHOP mRNA regulates translation of the downstream ORF (Jousse et al., 2001) .
uORF regulation of translation and eIF2a phosphorylation are central components of an integrated stress response (Young and Wek, 2016) . Four kinases respond to different environmental stresses and phosphorylate eIF2a serine 51: PERK responds to ER stress; HRI responds to oxidative stress and heat shock; PKR responds to viral infection; and GCN2 is a nutrient sensor. Correspondingly, cellular stress, through any one of these A) During ''conventional'' translation, the TC composed of eIF2, GTP, and Met-tRNA is joined by the 40S ribosomal subunit to form a 43S PIC. The PIC interacts with eIF4F (composed of three factors: the cap binding protein eIF4E, the scaffold protein eIF4G, and the RNA helicase eIF4A) of the mRNA 5 0 cap. The 40S then scans until it stalls at usually the first AUG, which often resides within a Kozak sequence. The 60S is then recruited, and the full ribosome commences polypeptide synthesis. (B) One type of uORF translation is illustrated, in which a non-canonical CUG in the uORF is the initiating codon, and translation of the uORF inhibits translation of the downstream ORF. (C) RAN translation proposes that the 40S and 60S ribosomal subunits directly bind the expanded repeats in mRNA through an unknown mechanism.
kinases, can modulate uORF and downstream ORF translation, which may result in unique biological responses depending on the cell type.
Abnormal Translation Products and Potential Translation Mechanisms in Repeat Expansion Disorders
One highly specialized cell type is the neuron, which can live for decades without undergoing cell division. Although these cells can endure even when encountering various stresses, in some neurological diseases, they undergo a remarkable molecular reorganization. Repeat expansion disorders are a set of more than 30 genetic diseases, mostly of the nervous system, that are caused by expansion of short repeat sequences of 3-6 nucleotides in a host gene's coding sequences, introns, or 5 0 and 3 0 untranslated regions (UTRs) (Zhang and Ashizawa, 2017) . During the last two decades, unconventional translation products from various expanded repeat sequences have been repeatedly detected in the nervous system of affected individuals. Three mechanisms have been proposed to account for the generation of these disease-specific proteins: (1) ribosomal frameshifting (Gaspar et al., 2000) , (2) repeat-associated non-AUG (RAN) translation (Zu et al., 2011) , and (3) near-cognate start codon initiated translation (Sellier et al., 2017) .
Ribosomal Frameshifting
Beginning with the work of Jacks and Varmus (Mardon and Varmus, 1983; Jacks and Varmus, 1985; Jacks et al., 1988) , it has become clear that most retroviruses, including HIV, utilize ribosomal frameshifting as an obligatory component of their life cycle. Frameshifting can be highly efficient and driven by a combination of a 7-base ''slippery'' RNA sequence and an RNA pseudoknot 3 0 to the site of frameshifting (Chamorro et al., 1992) . Beyond viruses, frameshifting is also found frequently in bacteria and known for some eukaryotic mRNAs (Caliskan et al., 2015) . Similar frameshifting appears to be a component in some polyglutamine diseases in which polyglutamine tracts are synthesized from expanded CAG repeats in frame with the coding regions of respective host genes (Orr and Zoghbi, 2007) . For example, in spinocerebellar ataxia type 3 (SCA3), ataxin 3 contains CAG repeats whose in-frame translation produces an expanded polyglutamine track; however, polyalanine-containing proteins are also generated in patient neurons (Gaspar et al., 2000) . Using reporter constructs in which different tags were engineered into separate reading frames, polyalanine synthesis was initially proposed to be caused by ribosomal slippage into the GCA frame in a repeat-length-dependent manner, although the slippage site was not identified (Toulouse et al., 2005) . In both Drosophila and mammalian neurons, production of polyalanine may be a key component of CAG repeat toxicity (Stochmanski et al., 2012) .
In Huntington's disease (HD), the most common CAG repeat disease, the repeats are in-frame with the huntingtin ORF, producing polyglutamine after codon number 17 in huntingtin (HTT). Nevertheless, both polyserine and polyalanine-encoded by the +1 and À1 frames of expanded CAG repeats, respectively-have been detected in autopsy samples of HD patients and in a transgenic mouse model of HD (Davies and Rubinsztein, 2006; Bañ ez-Coronel et al., 2015) . Frameshifting has been established to account for production of polyserine or polyalanine linked to the amino terminal portion of huntingtin. This frameshifting can occur within the expanded CAG repeats and is enhanced by depletion of the charged glutaminyl-tRNA that pairs to the CAG codon (Girstmair et al., 2013) . Detailed mass spectrometry and molecular analysis revealed that a UUCC sequence at the 5 0 end of CAG repeats in the Huntingtin coding region initiates the +1 frameshifting, and the effect of the UUCC sequence is enhanced by increased formation of stem-loop structures by expanded CAG repeats, providing a specific molecular mechanism for potential ribosomal frameshifting in HD patient cells (Saffert et al., 2016) .
RAN Translation
Polyalanine has also been detected in tissues of patients with another CAG repeat disease (SCA8) and in mouse models of the disease (Zu et al., 2011) . Here, CAG repeats are in-frame with the coding sequence of ataxin 8 (ATXN8). Rather than frameshifting, it has been proposed that polyalanine is produced by a different, unconventional translation mechanism, repeat associated non-AUG (RAN) translation, in which initiation in any of the three reading frames within expanded CAG (or other) repeats is thought to occur internally (Zu et al., 2011 ; Figure 1C ), seemingly consistent with the internal ribosome binding of mRNA observed by Nirenberg and Khorana decades ago using cell-free extracts primed with synthetic polyribonucleotides (Nirenberg and Matthaei, 1961; Nishimura et al., 1964) . Expression of engineered repeat-containing ATXN8 or HTT mRNA with multiple stop codons 5 0 to the CAG repeats in the +1 and +2 frames has shown that RAN translation certainly occurs under certain experimental conditions (Zu et al., 2011; Bañ ez-Coronel et al., 2015) . Whether this process requires poly(A) tail or other ciselements remains unknown. Abnormal disease-specific repeat proteins proposed to be synthesized from both sense and antisense transcripts through RAN translation have also been detected in brain tissues of patients with CTG repeat expansion in the 3 0 UTR of DMPK in myotonic dystrophy type 1 (DM1) (Zu et al., 2011) , patients with GGGGCC repeat expansion in the first intron of C9ORF72 that causes both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (Ash et al., 2013; Mori et al., 2013; Zu et al., 2013) , and patients with CCTG repeat expansion in the first intron of ZNF9 in myotonic dystrophy type 2 (DM2) (Zu et al., 2017) . Thus, RAN translation is posited to be a general phenomenon in various repeat expansion disorders (Cleary and Ranum, 2017) .
Near-Cognate Start Codons
Near-cognate start codon-initiated translation is a third mechanism that can yield mono-or di-peptide-containing proteins from translation of nucleotide repeats. The founding example of this came from fragile X-associated tremor/ataxia syndrome (FXTAS), which is caused by CGG expansion (55-200 repeats) in the 5 0 UTR of the fragile X mental retardation 1 (FMR1) gene (Hagerman and Hagerman, 2016) . The GGC frame of these repeats encodes polyglycine (FMRpolyG), which is indeed detected in FXTAS patient brains (Todd et al., 2013; Sellier et al., 2017) . The production of polyglycine does not seem to be mediated by RAN translation; rather, it requires a cap-dependent scanning mechanism for translation initiation (Kearse et al., 2016) and depends on an upstream, in-frame ACG near-cognate start codon embedded in a Kozak consensus sequence (Sellier et al., 2017) . The expanded CGG repeats create a large uORF 5 0 to the FMR1 open reading frame. Cap-dependent ribosome scanning that initiates at the ACG codon produces a protein with an N-terminal methionine and a short polypeptide, followed by polyglycine, and then a 42-amino-acid C terminus, all encoded by the sequences in what is typically annotated as the FMR1 5 0 UTR (Kearse et al., 2016; Sellier et al., 2017) . Both polyglycine and the 42-amino-acid C terminus that follows it appear to be key components driving disease, with deletion of the ACG near-cognate start codon abolishing polyglycine production and neurotoxicity (Sellier et al., 2017) .
The Translational Complexity of Expanded G 4 C 2 Repeats in C9ORF72-ALS/FTD
The complexity of atypical translation in repeat expansion diseases is most apparent in ALS, a fatal paralytic disease, and in FTD, the second-most common form of pre-senile dementia.
The most frequent genetic cause of these diseases is GGGGCC repeat expansion in the first intron of C9ORF72, with up to thousands of copies in the affected areas of the human nervous system (DeJesus-Hernandez et al., 2011; Renton et al., 2011 ; Figure 2A ). Since its discovery in 2011, rapid progress has been made in identifying dysregulated molecular pathways in C9ORF72-ALS/FTD (Gao et al., 2017) . Although repeat RNAs themselves may be partially responsible for neurotoxicity, accumulating evidence suggests that dipeptide repeat (DPR) proteins are pathogenic (Gitler and Tsuiji, 2016 (Ash et al., 2013; Mori et al., 2013; Zu et al., 2013) , albeit different investigators have reported highly divergent levels and number of neurons affected. Although poly(GP) proteins are synthesized predominantly from the sense repeats (based using antisense oligonucleotides to trigger RNase H-dependent destruction of the C9ORF72 sense strand RNAs) (Gendron et al., 2017) , they can also be produced from the antisense strand with a different C terminus (Zu et al., 2013) . Thus, they probably should be considered as two different proteins. In fact, because we do not know the precise translation initiation and termination sites on repeat-containing RNA in human cells, the diversity of DPR proteins could be much larger than detected thus far. Because the intron containing expanded G 4 C 2 repeats appears to be spliced out efficiently in human cells (Tran et al., 2015) , some DPR proteins might be produced from RNAs without other regulatory elements that are typically present in mRNAs, including the 5 0 cap and the poly(A) tail. However, experimental evidence is still lacking to definitively demonstrate the nature of the RNAs that are translated for DPR protein production. This is an important unresolved issue because the template for translation, spliced intron or unspliced pre-mRNA, may determine which translation mechanism(s) is at play. Nonetheless, here, we speculate that ALS/FTD-linked DPR proteins can be synthesized by any of the three mechanisms introduced above: RAN translation of either the repeat-containing excised intron or the pre-mRNA, ribosomal scanning for a near-cognate start codon, or translational frameshifting producing chimeric DPR products after initiation by either RAN translation or a near-cognate start codon (Figure 2) .
We would like to emphasize that it is not established yet which mechanism(s) is primarily responsible for production of endogenous DPR proteins in human cells where expanded G 4 C 2 repeats are expressed in their native molecular context and at a low level. Consider, for example, that in the sense strand RNA 5 0 to expanded G 4 C 2 repeats, a near-cognate CUG start codon is embedded in a good Kozak sequence and in-frame with poly(GA), the most abundant DPR protein in C9ORF72-ALS/FTD patient brains (Mackenzie et al., 2015) . It is thus possible that poly(GA) might be synthesized through a conventional ribosomal scanning mechanism ( Figure 2D ). Poly(GP), on the other hand, is mostly synthesized from the sense transcripts (Gendron et al., 2017) and encoded by the second reading frame that has an in-frame UAG translation terminator juxtaposed just 5 0 to the G 4 C 2 repeats. Thus, it may be produced either through RAN translation ( Figure 2E ) and/or in combination with other mechanisms. It is not obvious to predict where poly(GR) synthesis begins. RAN translation is plausible, although 26 codons are in-frame with poly(GR) in the sequence 5 0 to the repeats but whose role in poly(GR) synthesis is unknown. Similarly, although the transcription start and termination sites for C9ORF72 repeats-containing antisense transcripts are unknown, long stretches of amino acids are potentially encoded upstream and in-frame with poly(PG) and poly(PR) in antisense transcripts that contain several AUG, CUG, and putative Kozak sequences, raising the possibility that some or all of these DPR proteins are synthesized by usage of AUG or near-cognate start codons upstream of the expanded repeats ( Figure 2G ). These possibilities have not yet been tested experimentally.
In principle, ribosomal frameshifting can also occur in C9ORF72-ALS/FTD (Figure 2F ), as this process is enhanced by downstream RNA pseudoknots (Chamorro et al., 1992) or G-quadruplexes (Yu et al., 2014) , the latter a secondary structure readily formed by expanded G 4 C 2 repeat RNA (Reddy et al., 2013) . Moreover, although widely assumed to be pure repeats, we caution that this may not be the case in C9ORF72-ALS/FTD. It is plausible that the somatic expansion that produces up to thousands of G 4 C 2 repeats is accompanied by loss or gain of one or more nucleotides, thereby driving production of chimeric dipeptides. Interrupted G 4 C 2 repeats can potentially be generated by DNA replication stalling and/or template slippage at expanded repeats (Viterbo et al., 2016) , resulting in the activation of post-replication repair pathways that can introduce errors in the sequence (Lee and Myung, 2008) . Moreover, DPR proteins either directly or indirectly increase DNA damage in human C9ORF72 cells (Lopez-Gonzalez et al., 2016; Farg et al., 2017; Walker et al., 2017) . Loss of TDP-43, a key pathological protein in more than 95% of ALS cases (Ling et al., 2013) , compromises transcriptioncoupled DNA repair (Hill et al., 2016) . Thus, an improper repair process in postmitotic neurons may also result in interrupted repeat sequences. Recognizing this, we speculate that a wide variety of DPR proteins may be produced in C9ORF72-ALS/FTD patients: pure DPR proteins of different lengths, DPR proteins with unique N-and/or C-terminal amino acid sequences, chimeric DPR proteins, and potentially DPR proteins containing other amino acids encoded by unknown nucleotide sequences embedded within G 4 C 2 repeats, each of which can be initiated either by near-cognate start codons or RAN translation.
Concluding Remarks
The discovery of abnormal mono-and di-peptide proteins in repeat expansion diseases, especially in C9ORF72-ALS/FTD, has uncovered unexpected aspects of protein translation and generated enormous interest in how these proteins are synthesized. It remains to be determined the extent to which each of the proposed mechanisms-frameshifting, RAN translation, or uORF translation-are used in human cells where expanded nucleotide repeats are expressed in their native molecular contexts. Of course, these mechanisms are not mutually exclusive. Possible therapeutic interventions to alleviate disease protein toxicity may be based on specific translational mechanisms, underscoring the importance of understanding these basic molecular processes. We speculate, for example, that the composition of DPR proteins in C9ORF72-ALS/FTD may be much more complex than initially thought, depending on the translational mechanisms operating in a specific cell type, which may also partially explain selective neuronal vulnerability in these neurodegenerative disorders. Because aging is the major risk factor, it is possible that increased unconventional translation in disease may be one of the downstream responses to pathogenic stresses. It will be critical to determine how various chronic stresses influence the efficiency of each unconventional translation mode in human neurons. Finally, our prediction is that research on repeats and their translation is likely to continue to uncover novel insights into the biology of translation, as well as contributing to uncovering pathogenic mechanisms of disease.
